Skip to main content
logo
XORTX Therapeutics Inc. (XRTX)
0.3791
+0.0341 (9.88%)
Inactive · Last trade price on Mar 27, 2026

XORTX Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Quarter
CurrentQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021Q3 2021
Period Ending
Mar '26 Jun '26 Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Sep '23 Jun '23 Mar '23 Dec '22 Sep '22 Jun '22 Mar '22 Dec '21 Sep '21
Market Capitalization
343443445611511128121618252745
Market Cap Growth (YoY)
261.13%9.54%-21.70%-0.50%-11.38%-37.86%-66.09%-14.83%-55.87%-52.76%28.18%-60.29%-31.35%-36.24%-66.97%-56.34%-65.00%25.10%43.86%182.78%398.35%
Enterprise Value
24233212226-054-2356212341
Last Close Price
0.382.172.042.814.054.534.805.658.209.5018.5011.5526.9929.2120.9336.3654.4563.4587.7592.25215.33

Price Ratios

Fiscal Quarter
CurrentQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021Q3 2021
Period Ending
Mar '26 Jun '26 Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Sep '23 Jun '23 Mar '23 Dec '22 Sep '22 Jun '22 Mar '22 Dec '21 Sep '21
PE Ratio
--------1.19--3.72--2.14--------20.09-
PB Ratio
1.230.682.221.882.141.691.331.182.232.044.311.001.771.580.921.662.021.932.362.01-13.39
P/TBV Ratio
1.351.272.592.062.371.871.421.252.442.184.611.031.821.610.941.712.071.972.412.05-

Financial Efficiency

Fiscal Quarter
CurrentQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021Q3 2021
Period Ending
Mar '26 Jun '26 Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Sep '23 Jun '23 Mar '23 Dec '22 Sep '22 Jun '22 Mar '22 Dec '21 Sep '21
Debt / Equity Ratio
--0.010.020.030.040.010.010.030.030.010.000.010.010.010.010.010.01---
Net Debt / Equity Ratio
-0.18-0.18-0.18-0.40-0.57-0.48-0.69-0.73-1.05-1.11-1.53-0.74-0.83-0.83-0.87-1.48-1.12-1.08-1.16-1.131.18
Net Debt / EBITDA Ratio
0.460.470.100.340.480.400.700.970.820.921.000.710.760.820.961.131.121.712.796.512.61
Net Debt / FCF Ratio
0.200.200.090.300.380.320.620.660.550.680.710.520.570.700.881.151.031.361.953.108.72
Quick Ratio
1.591.590.371.581.451.512.533.291.351.4811.344.259.2815.3613.256.966.3013.7418.3026.970.42
Current Ratio
3.593.590.872.111.621.782.783.531.401.6013.684.939.4415.8213.697.216.6614.0919.3728.780.63
Return on Equity (ROE)
-199.25%-192.02%-116.40%-129.76%-120.32%-91.96%17.92%-97.06%26.19%-338.58%201.28%-79.11%-82.25%-91.28%-139.46%-55.35%-48.97%-89.60%582.10%-
Return on Assets (ROA)
-23.55%-70.51%-52.70%-43.16%-55.31%-52.09%-28.60%-35.11%-43.10%-26.89%-27.88%-38.45%-42.70%-38.12%-52.56%-42.33%-40.52%-40.27%-22.19%-8.21%
Return on Capital Employed (ROCE)
-38.70%-38.70%-189.30%-121.80%-122.40%-125.20%-101.70%-78.40%-133.00%-123.50%-68.20%-106.80%-110.50%-102.70%-91.70%-85.10%-82.70%-51.90%-31.80%-13.70%45.60%

Yields

Fiscal Quarter
CurrentQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021Q3 2021
Period Ending
Mar '26 Jun '26 Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Sep '23 Jun '23 Mar '23 Dec '22 Sep '22 Jun '22 Mar '22 Dec '21 Sep '21
Earnings Yield
-103.59%-99.57%-97.14%-67.89%-46.05%-54.86%-27.31%-84.25%-15.47%-26.88%-31.19%-46.74%-68.92%-62.52%-81.84%-66.39%13.02%-18.37%-9.09%-4.98%-19.75%
FCF Yield
-107.98%-135.82%-92.23%-70.76%-69.99%-89.71%-83.00%-93.54%-85.90%-79.92%-50.38%-142.67%-82.56%-75.40%-107.18%-77.26%-54.01%-41.40%-25.21%-18.07%-1.01%
Buyback Yield / Dilution
-64.48%-113.52%-86.30%-99.77%-67.26%-30.47%-53.84%-63.88%-45.26%-45.26%-25.91%-25.74%-38.49%-38.49%-33.68%-15.70%-38.17%-38.54%-57.76%-78.80%-35.96%
SEC Filings: 10-K · 10-Q